M. Giannotta

517 total citations
9 papers, 170 citations indexed

About

M. Giannotta is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, M. Giannotta has authored 9 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 3 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in M. Giannotta's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). M. Giannotta is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). M. Giannotta collaborates with scholars based in Italy and United States. M. Giannotta's co-authors include Mónica Milla, Gherardo Tapete, Giacomo Emmi, Elena Silvestri, Siro Bagnoli, Filippo Pieralli, Maddalena Grazzini, Vito Annese, Natalia Manetti and Carlo Nozzoli and has published in prestigious journals such as Annals of the Rheumatic Diseases, Inflammatory Bowel Diseases and Value in Health.

In The Last Decade

M. Giannotta

8 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Giannotta Italy	5	84	70	43	35	28	9	170
Laura Banov Italy	9	40 0.5×	23 0.3×	49 1.1×	30 0.9×	30 1.1×	21	234
Amanda B. Grimes United States	9	35 0.4×	14 0.2×	46 1.1×	30 0.9×	6 0.2×	37	226
Fiorella Cañete Spain	8	116 1.4×	96 1.4×	47 1.1×	46 1.3×		37	184
Jessica Harris United States	6	18 0.2×	37 0.5×	24 0.6×	58 1.7×	16 0.6×	12	176
Georgios Theocharis Greece	9	68 0.8×	106 1.5×	15 0.3×	117 3.3×	2 0.1×	25	243
J.E.G.M. Stoot Netherlands	8	13 0.2×	39 0.6×	14 0.3×	44 1.3×	9 0.3×	15	197
David Choi United States	10	142 1.7×	107 1.5×	44 1.0×	52 1.5×	1 0.0×	43	237
Philippe Van Hootegem Belgium	6	131 1.6×	106 1.5×	59 1.4×	51 1.5×	1 0.0×	11	202
O. Hinschberger France	9	8 0.1×	77 1.1×	44 1.0×	17 0.5×	9 0.3×	17	229
Rifat Zaman United States	6	37 0.4×	136 1.9×	128 3.0×	36 1.0×		9	291

Countries citing papers authored by M. Giannotta

Since Specialization

Citations

This map shows the geographic impact of M. Giannotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Giannotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Giannotta more than expected).

Fields of papers citing papers by M. Giannotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Giannotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Giannotta. The network helps show where M. Giannotta may publish in the future.

Co-authorship network of co-authors of M. Giannotta

This figure shows the co-authorship network connecting the top 25 collaborators of M. Giannotta. A scholar is included among the top collaborators of M. Giannotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Giannotta. M. Giannotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tapete, Gherardo, Lorenzo Bertani, Erica Nicola Lynch, et al.. (2021). Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry. Inflammatory Bowel Diseases. 28(1). 62–69. 27 indexed citations

2.

Anelli, Maria Grazia, Cinzia Rotondo, M. Giannotta, et al.. (2017). AB0250 The adipose tissue as predictive factor of disease activity in rheumatoid arthritis patients: evaluation of body fat composition by bioelectrical impedance analysis and ultrasonography. Annals of the Rheumatic Diseases. 76. 1135–1136. 1 indexed citations

3.

Giannotta, M., et al.. (2017). Chest x-ray and HRCT findings in influenza A/B pneumonia as a predictor of clinical course and intensive care hospitalisation. 1 indexed citations

4.

Bagnoli, Siro, Natalia Manetti, Saverio Caini, et al.. (2016). Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy. Digestive and Liver Disease. 48(12). 1432–1437. 7 indexed citations

5.

Manetti, Natalia, Siro Bagnoli, Francesca Rogai, et al.. (2016). Disease Course and Colectomy Rate of Ulcerative Colitis. Inflammatory Bowel Diseases. 22(8). 1945–1953. 16 indexed citations

6.

Giannotta, M., Gherardo Tapete, Giacomo Emmi, Elena Silvestri, & Mónica Milla. (2015). Thrombosis in inflammatory bowel diseases: what’s the link?. Thrombosis Journal. 13(1). 14–14. 99 indexed citations

7.

Lazzaro, Carlo, Maria Cappello, C.C. Cortelezzi, et al.. (2014). Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole Study. Value in Health. 17(7). A570–A571.

8.

Giannotta, M., S. Genise, Siro Bagnoli, et al.. (2012). P.16.14 LOSS OF EFFICACY AND ADVERSE DRUG REACTIONS DURING INFLIXIMAB THERAPY IN IBD PATIENTS ARE RELATED TO THE APPEARANCE OF ANTI-INFLIXIMAB ANTIBODIES. Digestive and Liver Disease. 44. S194–S194. 1 indexed citations

9.

Vannucchi, Vieri, et al.. (2011). Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease.. PubMed. 20(2). 201–3. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact